Dr Henk Luiting speaks to ecancer at EMUC 2019 in Vienna about following up from MRI scans in low-grade prostate cancer patients.

He expands on the work of the PRIAS study which is a large exploration of low-grade prostate cancer risk men.

Dr Luiting explains some of the pros and cons of MRI scans, with emphasis on knowing when to target biopsy.